BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31135268)

  • 1. Advancement in the development of heterocyclic nucleosides for the treatment of cancer - A review.
    Mirza AZ
    Nucleosides Nucleotides Nucleic Acids; 2019; 38(11):836-857. PubMed ID: 31135268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and anticancer activity of novel C6-piperazine substituted purine steroid-nucleosides analogues.
    Huang LH; Xu HD; Yang ZY; Zheng YF; Liu HM
    Steroids; 2014 Apr; 82():1-6. PubMed ID: 24378780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer activity of nucleoside analogues: a density functional theory based QSAR study.
    Sarmah P; Deka RC
    J Mol Model; 2010 Mar; 16(3):411-8. PubMed ID: 19626352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anticancer activities of novel 8-azapurine carbocyclic nucleoside hydrazones.
    Wang Y; Yan H; Ma C; Lu D
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4461-3. PubMed ID: 26364944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, structural characterization and biological evaluation of 4'-C-methyl- and phenyl-dioxolane pyrimidine and purine nucleosides.
    Franchini S; Battisti UM; Sorbi C; Tait A; Cornia A; Jeong LS; Lee SK; Song J; Loddo R; Madeddu S; Sanna G; Brasili L
    Arch Pharm Res; 2017 May; 40(5):537-549. PubMed ID: 27615010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the anticancer activity of nucleoside analogues: a QSAR model approach using an internally consistent training set.
    Helguera AM; Rodríguez-Borges JE; García-Mera X; Fernández F; Cordeiro MN
    J Med Chem; 2007 Apr; 50(7):1537-45. PubMed ID: 17341060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico studies toward the discovery of new anti-HIV nucleoside compounds through the use of TOPS-MODE and 2D/3D connectivity indices. 2. Purine derivatives.
    Vilar S; Estrada E; Uriarte E; Santana L; Gutierrez Y
    J Chem Inf Model; 2005; 45(2):502-14. PubMed ID: 15807516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments to improve the efficacy of cytotoxic nucleoside analogues.
    Jordheim LP; Galmarini CM; Dumontet C
    Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):163-70. PubMed ID: 18221034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and cytotoxicity of 4-amino-5-oxopyrido[2,3-d]pyrimidine nucleosides.
    Girardet JL; Gunic E; Esler C; Cieslak D; Pietrzkowski Z; Wang G
    J Med Chem; 2000 Oct; 43(20):3704-13. PubMed ID: 11020285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Methylpurine derived sugar modified nucleosides: Synthesis and in vivo antitumor activity in D54 tumor expressing M64V-Escherichia coli purine nucleoside phosphorylase.
    Hassan AEA; Abou-Elkhair RAI; Parker WB; Allan PW; Secrist JA
    Eur J Med Chem; 2016 Jan; 108():616-622. PubMed ID: 26724729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The unsaturated acyclic nucleoside analogues bearing a sterically constrained (Z)-4'-benzamido-2'-butenyl moiety: Synthesis, X-ray crystal structure study, cytostatic and antiviral activity evaluations.
    Benci K; Wittine K; Radan M; Cetina M; Sedić M; Kraljević Pavelić S; Pavelić K; Clercq ED; Mintas M
    Bioorg Med Chem; 2010 Sep; 18(17):6249-57. PubMed ID: 20696582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in the Chemical Synthesis and Evaluation of Anticancer Nucleoside Analogues.
    Guinan M; Benckendorff C; Smith M; Miller GJ
    Molecules; 2020 Apr; 25(9):. PubMed ID: 32354007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New nucleoside analogues for the recognition of pyrimidine-purine inversion sites.
    Buchini S; Leumann CJ
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1199-201. PubMed ID: 14565379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Anticancer Properties of Novel Truncated Carbocyclic Nucleoside Analogues.
    Sivakrishna B; Islam S; Panda A; Saranya M; Santra MK; Pal S
    Anticancer Agents Med Chem; 2018; 18(10):1425-1431. PubMed ID: 29577866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and anticancer activity of fluorocyclopentenyl-purines and - pyrimidines.
    Yoon JS; Jarhad DB; Kim G; Nayak A; Zhao LX; Yu J; Kim HR; Lee JY; Mulamoottil VA; Chandra G; Byun WS; Lee SK; Kim YC; Jeong LS
    Eur J Med Chem; 2018 Jul; 155():406-417. PubMed ID: 29906687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleoside analogs as a radiosensitizer modulating DNA repair, cell cycle checkpoints, and apoptosis.
    Yasui H; Iizuka D; Hiraoka W; Kuwabara M; Matsuda A; Inanami O
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):439-452. PubMed ID: 31560250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of 2,6-dichloropurine bicyclonucleosides containing a triazolyl-carbohydrate moiety.
    Zhang Q; He P; Zhou G; Gu Y; Fu T; Xue D; Liu HM
    Carbohydr Res; 2013 Dec; 382():65-70. PubMed ID: 24211367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the synthesis and biological activities of 4'-(R)-hydroxy-5'-(S)-hydroxymethyl-tetrahydrofuranyl purines and pyrimidines.
    Yu HW; Zhang LR; Zhou JC; Ma LT; Zhang LH
    Bioorg Med Chem; 1996 Apr; 4(4):609-14. PubMed ID: 8735849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Base-Modified Nucleosides as Chemotherapeutic Agents: Past and Future.
    Burke MP; Borland KM; Litosh VA
    Curr Top Med Chem; 2016; 16(11):1231-41. PubMed ID: 26369814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological properties of 5-(1H-1,2,3-triazol-4-yl)isoxazolidines: a new class of C-nucleosides.
    Giofrè SV; Romeo R; Carnovale C; Mancuso R; Cirmi S; Navarra M; Garozzo A; Chiacchio MA
    Molecules; 2015 Mar; 20(4):5260-75. PubMed ID: 25812148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.